Interrupted time-series signals showed exacerbations increased before 2015 but dropped sharply after 2015 and continued ...

The retrospective claims database analysis looked at patients in the United States, where it is estimated that costs related to asthma are more than $80 billion annually. Two-thirds of patients with ...

Patients with asthma who used biologics during pregnancy had less risk for complications than those who did not, according to a poster presented at the American Thoracic Society International ...

Please provide your email address to receive an email when new articles are posted on . Data were derived from Carr WW, et al. Abstract 043. Presented at: AAAAI Annual Meeting; Feb. 24-27, 2023; San ...

In comparison with White patients, Black patients are prescribed more anti-IgE biologics for the treatment of asthma, whereas Hispanic patients are prescribed fewer anti-IL-5 biologics, a ...

Results showed annualized asthma exacerbation rates were reduced in all age groups 6 months after compared with 6 months before initiating a biologic. Among patients with severe asthma, treatment with ...

Patients with severe asthma initiating biologics exhibit clinical responses and super-responses, but 40 to 50% do not meet response criteria, according to a study published online June 22 in Allergy.

Poorly controlled asthma during pregnancy can lead to serious complications, such as low birth weight, preterm delivery, and preeclampsia. For individuals with severe asthma, biologics—a new type of ...

multiple inhalers on a white background To what extent are patients with uncontrolled asthma switched to biologics due to poor treatment adherence vs lack of maintenance therapy efficacy? In patients ...

ANAHEIM, California — Patients with uncontrolled asthma are seen more often by primary care providers (PCPs) than by allergists, but a survey has found that 42% of PCPs are unfamiliar with the ...

Improved understanding of asthma endotypes, reflecting pathological processes that underlie asthma phenotypes, has informed the development of add-on biologic therapies for severe, treatment-resistant ...

Biologic drugs for asthma may be initiated or continued while conceiving or during pregnancy or breastfeeding following appropriate risk-benefit discussions and shared decision-making, a consensus ...